This is not the most recent version of the article. View current version (2 APR 2014)

Intervention Review

Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis

  1. Reshma Amin1,*,
  2. Valerie Waters2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 16 MAY 2012

Assessed as up-to-date: 12 APR 2012

DOI: 10.1002/14651858.CD009249.pub2

How to Cite

Amin R, Waters V. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD009249. DOI: 10.1002/14651858.CD009249.pub2.

Author Information

  1. 1

    The Hospital for Sick Children, Department of Pediatric Respirology, Toronto, Ontario, Canada

  2. 2

    Hospital for Sick Children, Department of Pediatrics, Division of Infectious Diseases, Toronto, Ontario, Canada

*Reshma Amin, Department of Pediatric Respirology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. reshma.amin@sickkids.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAY 2012

SEARCH

This is not the most recent version of the article. View current version (02 APR 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Baranzelli, F. Wallyn, S. Nseir, Infections bronchopulmonaires à Stenotrophomonas maltophilia et à Acinetobacter baumannii, Revue de Pneumologie Clinique, 2013, 69, 5, 250

    CrossRef

  2. 2
    Reshma Amin, Valerie Waters, Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis, The Cochrane Library,